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Drug discoveryIntegral membrane proteins, including G protein-coupled receptors (GPCR) and ion channels, mediate diverse
biological functions that are crucial to all aspects of life. The knowledge of themolecularmechanisms, and in par-
ticular, the thermodynamic basis of the binding interactions of the extracellular ligands and intracellular effector
proteins is essential to understand the workings of these remarkable nanomachines. In this review, we describe
how isothermal titration calorimetry (ITC) can be effectively used to gain valuable insights into the thermody-
namic signatures (enthalpy, entropy, afﬁnity, and stoichiometry), whichwould bemost useful for drug discovery
studies, considering that more than 30% of the current drugs target membrane proteins. This article is part of a
Special Issue entitled: Structural and biophysical characterisation of membrane protein–ligand binding.
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Integral membrane proteins play fundamental roles in all aspects
of human physiology, and mediate diverse functions from triggering
various signaling pathways to ion transport and metabolism. There
Fig. 1. A representative ITC dataset. (A) In the power vs. time titration curve, each peak
represents an injection of ligand into the sample cell that contains protein. (B) Typical
representation of ITC data. (C) Atypical representation of ITC data in the form of regular
high-afﬁnity binding curves.
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lar and intracellular worlds, are exquisitely regulated; not surprisingly,
their dysregulation leads to a wide variety of diseases. Considering 30%
of the human genome encodesmembrane proteins, very little is known
regarding the molecular mechanisms underlying their function, and
much less is known regarding the thermodynamic basis of their binding
interactions. In fact, a PubMed search failed to identify even a single
experimental thermodynamic characterization on intact mammalian
membrane proteins prior to 2009. This is in sharp contrast to soluble
proteins, and can be directly attributed to the major bottleneck of
requiring large amounts of the homogeneous, stable, and active prepa-
rations needed for structural and biophysical studies. Nevertheless, the
publication of two recent reports, one describing ligand binding to a
GPCR and another to a ligand-gated ion channel, bodes well for the
future [1,2].
Isothermal titration calorimetry (ITC) is the only experimental tech-
nique that can provide thermodynamic parameters (enthalpy, entropy,
binding constant, and stoichiometry) from a single titration, and most
importantly, the technique is label-free and therefore does not intro-
duce artifacts. ITC is robust, and in general, can measure binding afﬁni-
ties over 5 log units from ~100 μM to 1 nM. ITC's ability to measure
high afﬁnity interactions is worth noting, as this is not easily achieved
with other label-free methods. For instance, the most commonly used
technique of competitive binding requires radiolabeled ligands, and
similarly, in principle, ﬂuorescence spectroscopy can be used to mea-
sure high afﬁnity binding but requires the judicious introduction of
highly sensitive ﬂuorescent label at a speciﬁc site, which may not be
straightforward.
Considering that the availability of membrane proteins is limiting,
it is very important to have extremely sensitive instrumentation. Cur-
rently, the leading instruments are the Microcal ITC series and the TA
Instruments Nano-ITC. Typical traces obtained from multiple injections
(baseline subtracted) are shown in Fig. 1A. The area under each peak
represents the enthalpy (heat energy) associated with the corre-
sponding injection of ligand. Summing up all the heats from the indi-
vidual peaks yields the familiar titration curve for high-afﬁnity
binding (Fig. 1C). The ﬁgure also indicates the thermodynamic proper-
ties yielded by different parts of the ITC curve. Each enthalpy point rep-
resents an integrated injection peak. The amplitude of the curve is
proportional to the enthalpy of the reaction, the inﬂection point gives
the stoichiometry, and the width yields the ratio of the afﬁnity to the
protein concentration.
Thermodynamic insights from ITC studies are also of signiﬁcant
interest for drug development. A large fraction of the current drugs
targets GPCRs, and it has become quite evident from clinical data
that there is an immediate need for drugs that are more speciﬁc and
more potent in order to minimize side effects that could be quite detri-
mental. Most drug discovery approaches use computational tools and
modeling studies, which fail to capture the nuances of the molecular
underpinnings of binding interactions. Structural and dynamic mea-
surements using solution NMR studies of a wide variety of proteins
have shown substantial and subtle structural and dynamic changes be-
tween the free and bound forms. Even such detailed knowledge may
not be sufﬁcient to tease out the enthalpic and entropic components
that arise from packing and electrostatic interactions, structural and
dynamic changes, and the organization and release ofwater [3–5]. There-
fore, experimental thermodynamic data from ITC studies are ideally suit-
ed to provide this information, and will therefore play an integral role in
designing next-generation high-afﬁnity and high-speciﬁcity drugs.
Themajor challenges and limitations for studyingmembraneproteins
are two-fold. In addition to the requirement for relatively large amounts
of protein, there is also a need to keep the protein folded and functional in
native membrane lipid mimics (detergents) over a period of days. A
tremendous amount of work has gone into obtaining large amounts of
proteins mainly by optimizing heterologous expression in insect, yeast,
mammalian, and bacterial systems, and in parallel, developing andusing detergents that are mild and at the same time efﬁcient in solubiliz-
ing membranes [6,7]. Until recently, the major goals of these efforts have
been focused on structure determination, and indeed, a recent ﬂurry of
papers on structures of various GPCRs bodes well that protein expression
and obtaining sufﬁcient amounts of proteins will not be limiting [8–10],
andwill become less cumbersome, setting the stage for future ITC studies
of this highly challenging but important class of proteins.
We initially discuss various criteria that must be taken into con-
sideration for ITC, and in particular, focus on factors that are unique
to membrane proteins. We then discuss various ITC studies on mem-
brane proteins and what has been learned. The two sections are not
mutually exclusive, and whenever possible we have used currently
available published data to describe and highlight the experimental
criteria. Several comprehensive review articles are available for more
general details on technical aspects, experimental design, and applica-
tions of ITC [11–13].
2. How to set up an ITC experiment for membrane proteins
ITC is extremely sensitive; it is therefore essential to measure en-
thalpy changes only from binding interactions, and eliminate or signif-
icantly minimize enthalpy changes from other processes such as buffer
mismatch due to differences in pH or ionic strength, ligand dilution, and
in the case of membrane proteins, mismatch in detergent concentra-
tions. Further, ITC measurements, compared to other biophysical tech-
niques, require relatively large amounts of protein. This becomes all
the more challenging for membrane proteins, which are more difﬁcult
71K. Rajarathnam, J. Rösgen / Biochimica et Biophysica Acta 1838 (2014) 69–77to purify in large amounts. Asmuch as severalmilligramsmay be needed
for a series of experiments, depending on the speciﬁc system under in-
vestigation. However, substantially less material may be needed for the
investigation of very high afﬁnity interactions combined with very
large enthalpies of binding. Taking these factors into consideration, we
discuss various factors that should be considered before setting up the
experiment, and having done the experiment, discuss how tomaximally
interpret and get the most out of the data. For simplicity, we consider
only the case of independent and equal binding sites.
In general, prior knowledge from the literature on the binding af-
ﬁnities and/or stoichiometry is useful. For most receptors, functional
data generally exist, in which case it is very likely that EC50 values
also exist. EC50 is deﬁned as the ligand concentration at which 50%
of the maximal response is observed, and is determined by measuring
the functional response over many log units. This knowledge is most
useful as the binding afﬁnities often correlate with EC50. EC50 values,
in contrast to binding constants, are also more easily determined. In
the context of ITC experiments, it must also be remembered that there
is no correlation between enthalpy change and binding afﬁnity; if the
binding is predominantly entropically driven, the signal could be weak
even for high-afﬁnity interactions, and easily misinterpreted as lack of
binding.
2.1. Initial choice of protein and ligand concentrations
2.1.1. The 30, 30, 30 approach
Initial ITC measurements generally work best, when (i) the concen-
tration of protein is about 30 times higher than the expected dissocia-
tion constant, (ii) the ligand concentration in the syringe is about 30
times higher than the protein concentration in the cell, and (iii) about
30 injections of 5 μL are performed. In this section, we explain the ratio-
nale, and in the following sections also consider alternate approaches in
which the 30, 30, 30 approach is not practical.
2.1.2. Impact of protein and ligand concentrations on curve shape
It is important to choose a set of conditions under which the ITC
curve has a meaningful shape that allows the extraction of afﬁnity,
stoichiometry, and enthalpy in a reliable manner. A peculiar property
of ITC curves is that the shape primarily depends on the ratio of the
protein concentration to the dissociation constant. This ratio is deﬁned
as the c-value, where c = PN/KD (where P is the protein concentration
in the cell, N is the number of binding sites per proteinmolecule, and KD
is the dissociation constant). Note that when N ≥ 2, there are multiple
equal and independent binding sites on each protein, and the protein
concentration has to be multiplied by the number of sites (N) to obtain
the correct c-value. Fig. 2 shows how the shape of an ITC curve depends
on the c-value. Note that the shape depends only on the c-value, not onFig. 2. Dependence of the shape of ITC curves on the c-value (the ratio between protein
concentration and dissociation constant). The preferred range for the c-value is be-
tween about 3 and 100, with the optimum around 30.the speciﬁc protein. Only amplitudes or noise-levels will vary between
proteins; but the shape will be exactly as shown in Fig. 2 for a protein
with one binding site. The shape is also preserved for multiple equal
and independent sites, and only the numbers on the abscissa will
change.
Why do c-values matter? To answer this question, we ﬁrst consider
extremely high c-values. At a c-value of 3000 or more (ﬁlled triangle in
Fig. 2), the titration curve allows the extraction of just two parameters:
the stoichiometry is obtained from the molar ratio at which the signal
jumps, and the binding enthalpy from the difference in signal levels
before and after the jump. At intermediate c-values (around 30; ﬁlled
square in Fig. 2),more information is obtained. Namely, the progression
of the actual transition is seen, revealing the afﬁnity of the interaction.
At low c-values (below 3; ﬁlled circle in Fig. 2), not much information
can be obtained unless there is prior knowledge of some aspect of the
binding reaction, e.g. the stoichiometry [14]. If such knowledge exists,
then the known parameter can be ﬁxed in the curve ﬁt allowing the
extraction of the other parameters. This latter approach of ﬁxing the
stoichiometry has been applied in the case of membrane proteins;
ITC was used to characterize the binding of NAD(H) and NADP(H)
to Escherichia coli transhydrogenase, and due to the low c-value, the
authors assumed a 1:1 stoichiometry and were able to determine the
enthalpy and entropy of binding [15]. High protein concentrations
(>mM) would have been needed in this case to achieve c-values
>10, which is not practical due to non-availability or solubility,
highlighting the challenges of characterizing low-afﬁnity ligands.
2.2. Final choice of protein and ligand concentrations
The 30, 30, 30 approach is a good place to start if there is no a priori
knowledge about the afﬁnities, or if the signal is sufﬁciently large to
yield good parameter estimates without ﬁne-tuning the experimental
conditions. If the signal isweak but large enough to extract approximate
parameters, further optimization is necessary. One such approach in-
cludes optimizing the concentrations of protein and ligand [16]. It is
recommended to (i) use as high a protein concentration as possible
while maintaining the c-value b1000, (ii) make only 10 injections to
maximize the signal per injection, and (iii) set the ligand concentration
such that the ligand-to-protein concentration ratio after the ﬁnal injec-
tion is Rm = 6.4 ∗ c−0.2 + 13/c, but not smaller than 1.1 [16]. This
translates to a syringe concentration of Rm / (−1 + (1 + Rv)11),
where Rv is the ratio between the volume in each injection and the
cell volume, and c is the c-value. While 10 injections are sufﬁcient to
sample the transition within this approach, we recommend doing a
few more than 10 injections to establish the signal level after the
transition.
Sometimes, it may be difﬁcult to balance out the magnitude of the
signal against the shape of the curve. For example, in the case of the
membrane protein arginine–agmatine exchange transporter [17], sig-
nals of good magnitude were achieved using relatively large (20 μL)
injection volumes. Applying the principle from the last paragraph,
we can calculate that an optimal ligand concentration would have
been about double of what the authors used. The calculation is as fol-
lows: a c-value of 1.6 results from a protein concentration of 0.15 mM
and a Kd of 0.094 mM. The injection volume is 20 μL, and the cell volume
is likely 1400 μL (the exact instrument type was not reported), thus the
ratio of volumes, Rv, is about 0.014. Inserting these values gives
(6.4 ∗ 1.6−0.2 + 13 / 1.6) / (−1 + (1 + 0.014)11) = 82.5 for the ratio
between ligand syringe concentration and cell protein concentration,
i.e. 82.5 ∗ 0.15 = 12 mM arginine concentration in the syringe. What
was actually used was two-fold lower, viz. 6 mM. Note that any of the
parameters, protein concentration, ligand concentration, or injection
volume could have been modiﬁed. But the ligand concentration is the
most convenient in the given case. For agmatine, however, the used
concentration of 6 mM was optimal, as can be easily calculated with
the same equation (use 0.023 mM for the afﬁnity). Of course, much
Fig. 3. Typical shape of an ITC peak (“observed signal”) caused by a 15-second injection.
The ideal signal (“input signal”) would be obtained ifmixing, binding reaction, and instru-
ment response were inﬁnitely fast.
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were available.
In the case of the membrane protein transferrin receptor [18],
some of the titrations show sharp transitions and lack sufﬁcient
data points in the transition phase to accurately determine binding
afﬁnity. In this case, to get a curve shape that gives a better accuracy
for the afﬁnities, smaller injection volumes or lower injection concen-
trations could have been used at the expense of signal strength.
The choice of buffer can be another way to enhance or inadver-
tently reduce the signal [19]. Many binding reactions are accompa-
nied by a change in protonation state of either protein or ligand. In
that case, the buffer will respond by taking up or releasing protons,
resulting in buffer-dependent enthalpy change that must be either
added or subtracted from the experimentally observed heat release.
The relationship is given by the following equation, ΔHITC =
ΔHbinding + nΔHionization, where ΔHITC is the experimental observed
enthalpy, ΔHbinding is the buffer-independent binding enthalpy,
ΔHionization is the ionization enthalpy of the buffer, and n is the
number of protons transferred during binding. Thus it can be helpful
to use alternative buffers with large protonation enthalpies of opposite
sign. Buffer ionization enthalpies are available in the literature [20].
2.3. Effect of detergents
Detergent-related problems in the ITC signal can be identiﬁed
based on two major symptoms, viz. unusually large amplitudes and
unusual peak shapes. Detergents in presence of membrane proteins
exist in equilibrium between three forms — as a monomer; as a micelle,
which depends on the CMC that is known; and a mixed micelle with
the membrane protein where the CMC is generally not known. Protein–
detergent interactions will contribute to the overall thermodynamics of
the binding process. For instance, the release of bound detergents and/
or changes in micellar properties during the titration can inﬂuence the
heat released (enthalpy) to the extent that they obscure the heat release
directly related to the binding event. For example, in the case of the
human glycine receptor solubilized in DDM, extensive buffer mismatch
experiments using different detergent concentrations were carried out
to obviate large dilution heats [2]. This was all the more important as
the authors used individual protein fractions of different concentrations
for their ITC experiments, and so each fraction also contains different
amounts of detergents. A similar problem, though to a much lesser de-
gree, seems to have also occurred in ITC studies of photosystem II solubi-
lized in DDM [21]; this issue was not mentioned in the publication, but
evident in at least one of the titrations. Though such heats of dilution is
normally a mere nuisance, the possibility should be kept in mind that
coupling between ligand and detergent binding could affect the results
beyond an additive contribution.
For soluble proteins, the conventional approach is to dialyze the
protein against the same solution that is used for the ligand. However,
this is complicated for solutions containing detergents for reasons
outlined above. Only a fraction of the detergent is present in a mono-
meric form that can freely cross the dialysismembrane, and themicelles
may be too large to pass which is also dependent on the pore size of the
dialysis membrane used. Slow diffusion of detergents across the mem-
brane may not allow equilibrium to be reached in a reasonable amount
of time,making dialysis essentially impractical for biophysical studies of
membrane proteins. This is why a trial and error approach to ﬁnding the
right detergent concentration, as carried out for the glycine receptor,
may be superior compared to dialysis. However, dialysis could be a
viable option if protein levels are not limiting and are also highly stable.
For example, E. coli AcrAB-TolC membrane protein was extensively
dialyzed for ITC experiments, though the details of the extensiveness
and the stability and activity of the proteins were not described by the
authors [22].
Unusual peak shapes may point to undesired processes in the sample
cell, such as release or uptake of detergent upon ligand binding. Fig. 3shows the typical shape of an ITC peak (black points and gray line). This
shape results from the fact that heat transfer from the molecules in the
cell to the temperature sensor is not instant. If it were inﬁnitely fast,
then we would get the “input signal” shown as a dashed line in Fig. 3.
In this case, it has a breadth of 15 s, corresponding to a 15 second injec-
tion. The area is equal to the heat energy (enthalpy) change caused by
the injection. The distorted “observed signal” has still the same
area, but reﬂects the instrument response (~13 s time constant for
our instrument), and to a lesser degree on the kinetics of stirring.
Under normal circumstances, the peaks should always have the same
shape for any given ITC: an approximately exponential signal change
in one direction, followed an approximately exponential change in the
other direction — with a time constant that is reproducible across all
titrations on the respective instrument.
Further distortions of ITC peaks can occur if the binding of the ligand
is slow compared to the instrument response [23,24], or if the critical
micelle concentration (CMC) slowly readjusts. It is thus worthwhile to
monitor peaks for deviations from normal behavior. Such deviations
could be broadened peaks (slower exponential decay) or double
peaks. For example, SDS-mediated α-synuclein aggregation results in
very unusual peak shapes that could be attributed to the kinetic process
of both protein aggregation and micelle dilution [25]. Another example
is the broadened peaks that were observed in the case of transferrin re-
ceptor [18]. Some of the injection peaks include a slower exponential
decay or even double peaks. With the given information it is not easy
to tell whether the binding reaction itself is slow or there was a deter-
gent rearrangement such as association or dissociation. Itmay be some-
times desirable to attempt to reconstruct the “input signal” in order to
understand unexpected peak shapes. Relatively simple mathemati-
cal procedures are available for such purposes [26,27]. Normally, it
is sufﬁcient to use the longest time constant (the instrument response;
e.g. ~13 s for our instrument, as shown in Fig. 3) and do a ﬁrst order
deconvolution, as described in the cited chapters.
In general, it seems that the binding of ligands tomembrane proteins
is relatively slow. In many examples, injection peaks broaden as the
titration approaches 50% completion, and subsequently sharpen again.
This is the typical behavior expected for kinetic processes such as ligand
binding, and that they become visible in the experiment is indicative of
their slow speed compared to the response time of the ITC [24]. The
origin of double peaks is not clear a priori and could occur for various
reasons. The time frame of the peaks may give a clue to their origin.
Very sharp additional peaks may for example be due to a mechanically
generated heat of injection, caused by altered hydrodynamic properties
of lipid-containing solutions. Unusually broad secondary peaks are likely
due to kinetic processes that are triggered by the presence of the
injected ligand, such as slow fusion of vesicles.




Fig. 4. A schematic of the two-site interaction of chemokine ligand binding to its receptor.
Chemokine N-loop residues bind to the receptor N-terminal domain (deﬁned as Site-I)
and chemokine N-terminal residues bind to the receptor extracellular/transmembrane
residues (deﬁned as Site-II). In the case of RANTES, receptor binding and dimer interface
residues overlap and so dimeric RANTES cannot bind the receptor. In the case of IL-8,
dimer interface residues are located away from the receptor binding site, and so both
the monomer and dimer can bind the receptor.
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2.4.1. Choice of temperature
If the amplitude of the peaks is too small, a change in experimental
temperature may improve the situation. This is because binding
enthalpies often strongly depend on temperature. If the experimental
temperature happens to be just around the point where ΔH passes
through zero, not much of a heat signal will be observed.
2.4.2. Injection time and peak spacing
Protein samples may not be stable for a long time, and this can be
a factor towards shortening experiments. Such a decrease in time could
be achieved by using very short times between injections [28,29]. The
disadvantage is that the injection peaksmay overlap resulting in reduced
enthalpy values. An alternative approach for very fast ITCmeasurements
is theuse of the single injectionmethod [30]. Thismethod consists of one
single prolonged injection. Its shape is ﬁt to the applicable bindingmodel
to yield the thermodynamic parameters. The disadvantage is that the
single injectionmethod requires a very stable baseline andwill therefore
usually result in increased parameter uncertainty.
2.5. Choice of ITC instruments
To our knowledge there are two major brands of high sensitivity
ITC instruments that are useful for membrane proteins— the Microcal
(General Electric) VP-ITC and iTC200, with 1.4 and 0.2 ml cell volumes,
respectively, and the TA-instrument Nano-ITC which is available with
1.0 and 0.2 ml cell volumes [31]. We will focus on the Microcal instru-
ments for which more information is available, but the same principles
should apply to the TA-instruments aswell. Considering protein amounts
and achieving high concentrations are limiting for membrane proteins,
we discuss the advantages and disadvantages of VP-ITC (large volume)
and iTC200 (small volume) instruments.
In general, about three times less total protein is required for iTC200
compared to the VP-ITC. Because a smaller volume is required, the con-
centration of the protein needs to be two-fold higher. Formally, their
sensitivity is equal, but a smaller volume leads to a faster response
time, resulting in sharper, better-deﬁned peaks. Therefore, the iTC200
has about three-fold sharper peaks compared to the VP-ITC, because
the response time is three times shorter. However, its volume
is seven-fold lower (1.4 vs. 0.2 ml). To obtain comparable signals,
one needs then a three-fold lower concentration based on the response
time, but a seven-fold higher concentration based on the seven-fold
smaller volume, resulting in a factor of about two (7/3) in concentration.
Because the volume is seven times smaller, the total protein required is
three times less (7/3/7 = 1/3).
So, the advantage of a small cell volume is that less material is re-
quired and that the measurement is faster, leading to moderately high
throughput capabilities (up to about 50 samples per day). The tradeoff
is the higher protein concentration, leading to higher c-values. There-
fore, instruments with larger cell volumes are better suited for very
high afﬁnity measurements. If measurement time is a problem due to
stability issues, then iTC200 is better because of shorter measurement
time. If the elevated protein concentration is a problem, due to protein
aggregation, then VP-ITC is preferable.
3. ITC of membrane proteins
3.1. ITC studies of mammalian membrane proteins
3.1.1. ITC studies of a G protein-coupled receptor (GPCR) — human
chemokine receptor CCR5
GPCRs bind a diverse array of ligands from a photon to small mole-
cules and proteins, and play crucial roles from developmental biology
and sensory processes to regulating host immune response. A number
of current drugs actually target GPCR, and therefore knowledge of thestructural basis and molecular mechanisms underlying binding interac-
tions is of signiﬁcant interest andbeing actively pursued in both academia
and industry. Despite their importance, there is only one study in the
literature reporting an ITC study of a GPCR. Nisius et al. [1] have used
ITC to characterize the functional characteristics of a recombinant puriﬁed
CCR5 receptor by measuring binding to its native ligand RANTES. The
authors were successful in obtaining relatively high amounts of puriﬁed
receptor (~1 mg/l of culture) from baculovirus-infected Sf9 insect cells.
Screening a panel of detergents resulted in FosCholine-12 showing the
best results for solubility. Both circular dichroism (CD) and 1HNMR spec-
tra showed a folded receptor and characteristic spectral signatures of a
helical protein, and a conformation-speciﬁc antibody also recognized
the detergent-solubilized receptor. ITC studies of RANTES binding to the
receptor showed that the binding is exothermic; however, the measured
apparent binding afﬁnity of ~1 μM was substantially lower than the
nanomolar binding afﬁnities observed for the native receptor.
Large differences in binding and functional properties between
puriﬁed and membrane-bound proteins are not uncommon. These
differences could be a true reﬂection of the differences in membrane
environment and/or that the biophysical and functional methods are
limiting and do not capture the actual activity of the protein. Therefore
in the case of CCR5, did the puriﬁed receptors in detergentmicelles lack
some of the native interactions, and/or the ITC studies not carried out
under optimal conditions? Ligand binding involves two sites on the
receptor – the N-terminal domain (Site-I) and the extracellular loops
(Site-II) (Fig. 4) – and it is also well established that a GPCR exists as
an ensemble. It is possible that with the puriﬁcation scheme and/or
under the experimental conditions used, the receptor exists in and/or
adopts a lowafﬁnity conformation, and binding at Site-I does not trigger
the conformational change required for binding at Site-II. Various bio-
physical studies have indicated that CCR5 in detergent micelles exists
as both monomers and dimers. RANTES oligomerizes at physiological
pH, and so the authors use a mutant (E66S) that has a lower tendency
to aggregate. This is important, because previous binding studies have
shown that only the monomer, and not even the dimer can bind the
receptor. However, the binding and functional characteristics of themo-
nomeric vs. dimeric forms of the receptor are not known. Therefore, it is
possible that the lower afﬁnities could be due to differences in the
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the ligand to the monomeric vs. dimeric forms of the receptor.
From a technical point of view, these titrations are challenging due
to the low c-value (~5) that could be achievedwith the available receptor
amounts. Further, only a factor of 10 betweenGPCR and ligand concentra-
tion was achieved, whereas a factor of 30 would be desirable (30, 30, 30
criteria); therefore, using higher RANTES concentrations could have
resulted in a stronger signal. However, this may not be also practical
due to the tendency of the ligand to oligomerize. The authors doubled
the injection volume from the recommended 5 μL to 10 μL; this partially
compensated for the limitations of low c-value and low protein/ligand
ratio. Considering that the 30-30-30 criteria were not feasible, with
other parameters being constant, we propose the use of ~17 μL injection
volumes according to the criteria discussed in Section 2.2 [16]. How-
ever, for such large volumes, it is important to verify ﬁrst in a simple
water-to-water reference measurement whether the solution in the
syringe has sufﬁcient time to reach the sample temperature before
being injected, as a temperature mismatch would result in large peaks.
This study provides compelling proof-of-principle that ITC studies
of GPCRs are feasible and realistic, and at the same time highlights
some of the challenges. Future studies of other GPCRs, and also of
CCR5 using a monomeric RANTES, a receptor preparation containing
only monomers or dimers, data collection under more optimal condi-
tions, and receptors solubilized using different detergents are necessary
to provide the framework for formulating the experimental principles
for studying thermodynamics of GPCRs.
3.1.2. ITC studies of an ion channel — the human glycine receptor
The glycine receptor belongs to the class of pentameric ligand-gated
ion channels that rapidly respond to changes in extracellular effectors in
the neural signaling network. Recently, Wohri et al. have succeeded in
expressing high receptor levels in yeast and obtaining high quality ITC
data comparable to those for soluble proteins [2]. The authors have
succeeded in preparing awell folded, highly stable (over aweek), homo-
geneous, and active receptor using DDM as the detergent in high yields
(up to 5 mg/l of culture). However, the authors had to overcome multi-
ple hurdles at every step along the way from optimizing expression
vectors to minimizing experimental artifacts during ITC data collection.
The study highlights how a systematic approach, and the integration
of the expertise from molecular biology, heterologous protein expres-
sion, and detergents to ITC data collection are essential to be successful.
The design strategy involved the initial optimization of conditions for
protein homogeneity including cloning and characterizing a series of
mutants, optimizing conditions for stability includinguse of endogenous
ligands, and ﬁnally optimizing conditions for collecting ITC data.
The authors report the bindingof strychnine an antagonist andglycine
an agonist. The chemical structures of glycine and strychnine are quite
different, and these ligands bind with differing afﬁnities to distinct but
overlapping sites. Interestingly, the calorimetry data showed that the
binding of glycine is enthalpically driven and that of strychnine is entro-
pically driven. The data could be ﬁtted to a simple model, with both
ligands bindingwith a stoichiometry of one ligand to a single pentameric
receptor, and the afﬁnities were similar to those observed from radio-
ligand binding studies. These data together suggest that the puriﬁcation
scheme and the choice of detergent captured the native fold and function
of the receptor. A rigorous analysis of the data also suggests that
strychnine has additional low afﬁnity binding sites.
One of the challenges of ITC studies of membrane proteins is the
buffer mismatch that arises due to variations in detergent composi-
tion of the membrane proteins between fractions and between prep-
arations, and the difﬁculties encountered in quantifying the exact
amount of detergent present. DDM shows fairly high buffer mismatch
but is also one of the best detergents for membrane protein studies, as
was the case for the glycine receptor. Therefore, researchers carried
out a series of titrations with different detergent concentrations to
minimize buffer mismatch, and observed negligible mismatch onlyover a narrow window. It was also evident from these experiments
that minimizing buffer mismatch may not be possible at high total
DDM concentrations, and the authors propose that using protein frac-
tions containing high protein to low detergent ratio will minimize
buffer mismatch-related issues and yield the best and most reliable
data.
A comparison between glycine and strychnine binding highlights
the importance of optimal c-values. The c-values were >100 for
strychnine and ~1 for glycine. Thus, strychnine titrations yield recogniz-
able titration curves, whereas glycine titrations result in curves that are
more difﬁcult to interpret. Error limits for Kd are not provided, but they
should be quite high for glycine binding, likely above 100% in the linear
scale, whichmeans that only the order ofmagnitude, and not the actual
value, of the Kd can be assessed. A more reliable direct estimation of the
binding afﬁnity requires a higher receptor concentration, but will result
in a higher detergent concentration resulting in signiﬁcant buffer
mismatch and thereby rendering the data difﬁcult to interpret. On the
other hand,more reliable competition titrations resulted in signiﬁcantly
lower afﬁnity estimates than direct glycine titrations. Such competition
experiments are an excellent alternative for titrations with ligands
whose afﬁnity is out of range (high or low). The idea is that the presence
of aweaker afﬁnity ligand increases the Kd of the stronger afﬁnity ligand
Kd,app,strong = Kd,strong(1 + CweakKd,weak), where Kd,app,strong is the ap-
parent afﬁnity of the strong binder in the presence of the weak binder,
Kd,strong and Kd,weak are the intrinsic afﬁnities of the ligands, and Cweak
the concentration of the weak binder. In the case of glycine receptor,
Kd,weak was determined by ﬁrst measuring Kd,strong and then Kd,app,strong
at one value of C
weak
(a better approach would be to use a range of
concentrations). This approach will also work the other way around
for very strong afﬁnities: determining Kd,strong from measurements of
Kd,weak and Kd,app,strong [32].
Independent of c-value limitations, these studieswere able to validate
the currently proposedmechanismand stoichiometry of ligand transport.
This study also provides compelling proof-of-principle that ITC studies of
ion channels, and by extension of other membrane proteins, can yield
thermodynamic data comparable to those obtained for soluble proteins.
3.2. Bacterial membrane proteins
In contrast tomammalianmembrane proteins, ITC studies have been
reported for various bacterial and a few archaeal membrane proteins
(summarized in Table 1; refs. [15,17,18,21,28,29,33–40]). These include
transporters and pumps of metal ions, peptides, and proteins. Studying
bacterial membrane proteins, in general, does not require heterologous
expression, they tend to be more stable, and therefore obtaining rela-
tively large amounts of stable and folded proteins (>10 mg/l of culture)
is more straightforward.
Measuring the enthalpy, entropy, afﬁnity, and stoichiometry of bind-
ing for a number of these proteins have enabled the authors to propose
the structural basis of the binding (for proteins where structures are
available), and in other cases, the mechanisms of binding and models
for receptor assembly and cellular transport.Whereas some of the studies
exclusively used ITC alone in describing the binding interactions, others
used a combination of biophysical and functional techniques where calo-
rimetry data complemented other structural/functional data towards
describing the mechanism of binding and function. Whereas some of
the membrane proteins function as monomers, quite a few exist as
homooligomers and heterodimers. Despite better protein expression,
the challenges of studying these complex systems and of having to use
detergents are obvious in some of the studies, some of which have
poor signal-to-noise ratios, whereas others could have been performed
undermore optimal conditions.Wehave discussed someof these studies
in Section 2.
Higher stability of these proteins allows studies under conditions
not feasible for mammalian membrane proteins. For instance, in the
case of archaeal rhodopsins, the ITC studies of the WT were carried
Table 1
ITC studies of membrane proteins and receptor extracellular domains.
Membrane protein/ligand Detergent Ref.
A) Mammalian membrane proteins
i) Chemokine receptor CCR5/RANTES 0.5% FosCholine-12 Ref. [1]
ii) Glycine receptor/glycine and strychnine ~0.04 to 0.1% DDM Ref. [2]
B) Bacterial and other non-mammalian membrane proteins
i) E. coli transhydrogenase/NADH 0.1% Brij-35 Ref. [15]
ii) E. coli AdiC transporter/arginine 5 mM DM Ref. [17]
iii) N. meningitides transferrin receptor/transferrin 0.05% DDM Ref. [18]
iv) T. elongates PS II/herbicides 0.03% DDM Ref. [21]
v) E. coli AcrAB-TolC multidrug efﬂux system 0.02% DDM Ref. [22]
vi) E. coli iron transporter FhuA/microcin J25 1% OG Ref. [28]
vii) P. denitriﬁcans Surf1/heme 0.02% DDM Ref. [29]
viii) E. coli zinc transporter YiiP/Zn2+,
Cd2+, and Hg2+
0.05% DDM Ref. [34]
ix) E. coli vitamin B12 receptor/colicins 1% β-OG Ref. [35]
x) E. coli MDR EmrE/drugs 8% SDS/2% DDM Ref. [36]
xi) E. coli MDR EmrE and SugE/drugs 8% SDS/2% DDM Ref. [37]
xii) Archaeal rhodopsin/transducer protein 0.05% DDM Ref. [38]
xiii) A. aeolicus twin-arginine translocation
protein/signal peptide
0.02% LMNG Ref. [39]
xiv) E. coli NhaA Na+/H+ antiporter/Li2+ 0.04% DDM Ref. [40]
C) GPCR receptor domains
i) CXCR1 N-domain/IL-8 dimer and monomer Ref. [41]
ii) CXCR1 N-domain/IL-8 monomer Ref. [42]
iii) CXCR1 extracellular domains/IL-8 monomer Ref. [43]
iv) CCR5 N-domain/CD4/HIV gp120 Ref. [44]
v) PTH receptor N-domain/PTH Ref. [45]
vi) PTH receptor N-domain/PTH variants Ref. [46]
vii) C5a receptor N-domain variants/CHIP Ref. [47]
viii) C5a receptor N-domain variants/CHIP Ref. [48]
Abbreviations: LMNG — lauryl maltose neopentyl glycol; DDM — dodecyl maltoside;
OG — octyl glucoside; DM — decyl maltoside; SDS — sodium dodecyl sulfate.
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NaCl concentrations (400 mM) [38]. Krell et al. studied the binding
of the two individual subunits and the entire complex of the transferrin
receptor, and in addition, also studied the binding to various domains of
the individual subunits [18]. Further, transferrin exists in both apo and
holo (iron-bound) forms, and by characterizing the binding of both
forms, the authors were able to provide a thermodynamic basis of the
mechanism of transferrin receptor function.
Bacteria have multiple drug-resistance mechanisms, including the
expression of membrane transporters that efﬁciently clear drugs. E. coli
encodes two such transporters called SugE and EnrE. Sikora and Turner
have used ITC to study the binding of a family of quaternary ammonium
compounds (ethidium, methyl viologen, proﬂavin, TPP, and CTPC) to
these proteins in two different detergents, SDS and DDM, and in small
unilamellar vesicles (SUV) made from E. coli polar lipids [36,37]. These
transport proteins can withstand harsh treatments including exposure
to organic solvents, and so could be puriﬁed in large quantities in a
straightforward manner. The authors initially carried out a series of ex-
periments to obtain sufﬁcient signal by varying protein concentrations
in the cell, ligand concentration in the syringe, and eliminating buffer
constituents that decreased the signal-to-noise ratio. Such experiments
allowed the detailed thermodynamic characterization of the binding of
multiple ligands to two transporters in three different systems, including
in SUVs. DDM is a neutral detergent, SDS is negatively charged, and the
lipids used in the SUV preparation are neutral, and the properties of
the DDM and SDS micelles and the SUV vesicles are different in terms
of size and shape, among other parameters. The ITC data show that the
binding afﬁnities, stoichiometries, enthalpies, and entropies of the bind-
ing of various drugs to the two transporters, but for rare exceptions, did
not vary among membrane mimetics. To our knowledge, these are the
only ITC studies ofmembrane proteins reconstituted in SUVs. Essentially
similar thermodynamic parameters between SUVs and micelles are
striking, considering that SUVs are more similar to cells in shape andsize. These observations suggest that the presence of the membrane
environment is essential for a functional transporter and is not strictly
dependent on the type of membrane mimetic used. Considering that
these drugs are lipophilic, control experiments of binding to themicelles
and vesicles showed weak binding (Kd ~ mM) compared to the micro-
molar binding to the transporters. These experiments suggest that the
drug efﬂux is mediated by transporters and is not due to passive diffu-
sion across the membrane. Structural studies have shown that EmrE
forms oligomers, but ITC studies show that all of the drugs bound both
transporters with a 1:1 stoichiometry suggesting that oligomerization
is not essential for binding. These studies show how ITC can be effec-
tively used to describe the structural and thermodynamic basis and
the molecular mechanism underlying ligand–membrane protein
interactions.
3.3. Calorimetry of ligand binding to functional domains of GPCR class
of receptors
Considering the various challenges that face calorimetric studies
of intact receptors, some authors including us have taken a ‘divide
and conquer’ approach of characterizing binding interactions to the
receptor extracellular domains. These studies are all the more relevant
if such interactions could provide insights into the thermodynamic sig-
natures that are otherwise hard to come by. Examples in the literature
include ITC studies of ligand binding to chemokine, C5a, and parathyroid
receptor N-terminal domains (summarized in Table 1, refs. [41–48]). In
addition to providing stoichiometry, these studies have also provided
functional insights into ligand and receptor speciﬁcity and mechanistic
insights into ligand–receptor interactions.
Chemokines, a large family of protein ligands (MW ~ 8–10 kDa),
are atypical agonists for class-A GPCRs, as most agonists tend to be
small molecules. Receptor activation involves interactions between
the chemokine N-loop and receptor N-terminal residues (Site-I)
and between the chemokine N-terminal and receptor extracellular
loop/transmembrane residues (Site-II) (Fig. 4). Chemokines bind
their receptorswith nanomolar afﬁnity, but how the two sites contribute
to the overall afﬁnity, and the thermodynamic basis of binding, such as
whether the binding to two sites are independent or coupled, and the
role of enthalpy and entropy, are not known [49]. Further, chemokines
exist as both monomers and dimers, and the mode of binding, receptor
selectivity, and afﬁnity vary among different chemokine-receptor pairs
[50,51].
Chemokine CXCL8 exists as monomers and dimers, and binds two
receptors, CXCR1 and CXCR2. Whereas CXCR1 binds only the monomer
with high afﬁnity, CXCR2 binds both the monomer and the dimer with
high afﬁnity. ITC studies of the binding of both monomer and dimer to
the CXCR1 receptor N-domain peptide have shown that the dimer disso-
ciates on binding, providing a structural basis for the lower receptor afﬁn-
ity of the dimer [41], and that the binding of themonomer is enthalpically
driven [42]. A recent structure of CXCR1 has shown that the N-terminal
domain is unstructured [52]. Therefore, studies using isolated N-domain
peptides most likely mimic binding to the intact receptor, indicating
that ligand binding to the N-domain of the intact receptor is also
enthalpically driven. Structural studies of the CXCL8-receptor N-domain
complex have shown that a combination of packing/hydrophobic and
electrostatic interactions mediate the binding process [53]. The thermo-
dynamic signatures are interesting, because the entropic component of
the binding is relatively small. Structures and dynamic measurements
reveal that both the receptor and ligand, though structured, continue to
be dynamic in the bound form, suggesting that entropy does play a
role; further, it is possible that entropic contributions from the
release/reorganization of bound water on binding also play a role. Re-
cently, ITC was used to characterize IL-8 monomer binding to a series
of CXCR1 and CXCR2 receptor constructs that consisted of N-domain
(Site-I binding site) and/or an extracellular loop domain (Site-II binding
site) on a protein scaffold to understand whether Site-II inﬂuences the
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inﬂuences Site-I binding in the case of CXCR1 and not CXCR2, demon-
strating how studying soluble functional domains could provide valuable
knowledge, that is otherwise intractable, of the intact membrane-bound
receptors. HIV infection of the host cells involves binding of the viral
envelope protein gp120 to the CD4 receptor and chemokine CCR5 recep-
tor. CCR5 N-terminal domain contains sulfated tyrosines, which are
known to be critical for binding to gp120. Brower et al. have characterized
the binding of gp120 to the CCR5N-terminal sulfated andunsulfated pep-
tides using ITC in presence and absence of CD4, and show that the gp120
binds to the sulfated CCR5N-domain peptide only in the presence of CD4,
that the binding is mediated by both favorable enthalpic and entropic in-
teractions, and that the unsulfated peptide is inactive [44]. In addition to
providing molecular insights, these studies also indicate that compounds
containing sulfated aromatic compounds could act as potential inhibitors
of HIV entry.
The parathyroid (PTH) receptor is a class-B GPCR receptor, and in
contrast to class-A receptors, the N-domains of class-B receptors are
folded and structured and could be easily visualized to function as inde-
pendent structural and functional units. The structure of the ligand-
bound PTH receptor N-domain has been solved by X-ray crystallogra-
phy [45], providing insights into the binding speciﬁcity and how some
of the conserved residues unique to PTH receptors mediate the binding
process. In an independent study, ITC was extensively used to charac-
terize the binding afﬁnities of PTHpeptides of various lengths and single
substitution mutants of residues known to be important for binding,
with the overall goal of designing high afﬁnity drugs [46]. This study
was able to identify and conﬁrm various residues that function as hot
spots, and also showed that increasing hydrophobic interactions could
result in higher binding afﬁnities, paving the way for the future
structure-based design of therapeutics.
The C5a receptor, like chemokine receptors, is a class-A receptor,
and is characterized by N-terminal tyrosine sulfation that is essential
for function. Its endogenous ligandC5a is generated during complement
activation, and plays an important role in combating infection by acti-
vating the C5a receptor. At the same time, the C5a receptor is also an at-
tractive drug target, as a dysregulation in its response also results in
collateral tissue damage and disease. Interestingly, Staphylococcus
aureus secretes a protein called CHIPS, which binds to the C5a receptor
and prevents its activation, allowing the bacterium to evade the host
immune response. CHIPS binds to the sulfated receptor N-domain, and
ITC studies have shown that CHIPS bind to various singly and doubly
sulfated N-domain peptides with nM afﬁnities [47]. ITC measurements
of the unsulfated peptide showed reduced binding afﬁnities whereas
phosphorylated peptides showed similar nM binding afﬁnities, indicat-
ing that negative charge, and not sulfation in itself, is critical for the
binding process [48].
These studies using isolated receptor domains indicate that mem-
brane proteins can be classiﬁed into those which contain a soluble
ligand binding domain and those which do not, that thermodynamic
insights for the former class can be captured by measuring binding to
recombinant soluble ligand binding domains without any require-
ment for detergents, and that these measurements most likely reﬂect
binding to these domains in the full-length receptor. However, for the
latter class, binding measurements can be carried out only by using
detergent solubilized membrane proteins.
4. Conclusions
In this review, we have discussed the various studies on the thermo-
dynamic characterization of ligand-membrane protein interactions
using ITC;we have highlighted the knowledge gained and the challenges
that are multifactorial from purifying membrane proteins in large quan-
tities to experimental setup anddata analysis. Recent advances in protein
expression and puriﬁcation, detergents, instrumentation and data analy-
sis together have contributed to considerable progress, considering thatall of the published studies were carried out in the past decade, and
that the only two studies on mammalian membrane proteins were
reported in the last few years. We conclude that the recent successes
are a harbinger of what we can expect in the coming decades, and ITC
studies will undoubtedly provide valuable and unique knowledge on
the molecular mechanisms and to the drug discovery process for a
wide variety of human diseases.
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